Are statins effective for simultaneously treating dyslipidemias and hypertension?
نویسندگان
چکیده
منابع مشابه
Statins and Pulmonary Hypertension in Chronic Obstructive Lung Disease
Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...
متن کاملAre statins beneficial for the treatment of pulmonary hypertension?
Pulmonary hypertension (PH) is a condition characterized by vasoconstriction and vascular remodeling with a poor prognosis. The current medical treatments available are supportive care therapy and pulmonary vascular-targeted therapy. Targeted treatments for PH include prostacyclin analogs, endothelin receptor antagonists, and phosphodiesterase type 5 inhibitors; however, these treatments cannot...
متن کاملLetter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal?
IN A RECENT ISSUE of the American Journal of PhysiologyGastrointestinal and Liver Physiology, Schierwagen et al. (8) reviewed the outcomes of statins on liver and cardiovascular disease (CVD) (8). A few comments might be of interest. In 2010, our post hoc analysis of the GREek Atorvastatin and Coronary heart-disease Evaluation (GREACE) study (n 1,600) (3) showed that atorvastatin (average dose,...
متن کاملAntibiotics are effective at treating asthma
Health[1] Health[1]Asthma [2]Bacteria [3]Body [4]Diseases [5]Denmark [6]Videnskab.dk [7] Antibiotics reduced the number of sick days caused by asthma attacks in young children by more than 50 per cent, shows new study. A small revolution could be about to the hit the market in the treatment of asthma attacks: Antibiotics reduce the number of sick days of asthmatic children aged one to three yea...
متن کاملNew Drugs for Treating Dyslipidemia: Beyond Statins
Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment, 60% to 80% of residual cardiovascular risk still exists. The patients with familial hypercholesterolemia which results in extremely high level of low density lipoprotein cholest...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Atherosclerosis
سال: 2008
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2007.06.006